{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:11:06Z","timestamp":1790885466596,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Xiangya Excellent Physician Award (ZWY, 2013), Central South University","award":["ZWY, 2013"],"award-info":[{"award-number":["ZWY, 2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Autosomal dominant tubulointerstitial kidney disease (ADTKD) caused by a pathogenic variant in <jats:italic>UMOD<\/jats:italic> (ADTKD-<jats:italic>UMOD<\/jats:italic>) is a rare group of diseases characterized by hyperuricaemia with decreased urinary excretion of urate, gout and progressive chronic kidney disease. The mundane clinical characteristics often result in a failure to diagnose ADTKD-<jats:italic>UMOD<\/jats:italic>.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this report, we describe a 12-year-old boy who presented with polyarthritis, hyperuricaemia and tophi with a family history of 8 affected individuals. Clinical data, blood and urine samples of 3 affected members and 8 unaffected members were collected. Genetic testing of the eight genes (<jats:italic>UMOD<\/jats:italic>, <jats:italic>HPRT1<\/jats:italic>, <jats:italic>PRPS1<\/jats:italic>, <jats:italic>MTHFR<\/jats:italic>, <jats:italic>REN<\/jats:italic>, <jats:italic>HNF1b<\/jats:italic>, <jats:italic>URAT1<\/jats:italic> and <jats:italic>G6PC)<\/jats:italic> was performed using Sanger sequencing. A heterozygous missense variant (c.674C\u2009&gt;\u2009G; p.T225R) in <jats:italic>UMOD<\/jats:italic> was found in this boy, his older brother with the same phenotype and his mother with hyperuricaemia, gout and chronic kidney disease.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case highlights the importance of family history and genetic testing for definite diagnosis. This novel variant extends the spectrum of known <jats:italic>UMOD<\/jats:italic> gene variants and further supports the allelic heterogeneity of ADTKD-<jats:italic>UMOD<\/jats:italic>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-02022-1","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:12:03Z","timestamp":1598415123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A novel likely pathogenic variant in the UMOD gene in a family with autosomal dominant tubulointerstitial kidney disease: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingnan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuwen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-4292","authenticated-orcid":false,"given":"Xiqiang","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"issue":"3","key":"2022_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2018.03.019","volume":"72","author":"N Ayasreh","year":"2018","unstructured":"Ayasreh N, Bullich G, Miquel R, Furlano M, Ruiz P, Lorente L, Valero O, Garc\u00eda-Gonz\u00e1lez MA, Arhda N, Garin I, et al. Autosomal dominant Tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1. Am J Kidney Dis. 2018;72(3):411\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2022_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2015.28","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--a KDIGO consensus report. Kidney Int. 2015;88(4):676\u201383.","journal-title":"Kidney Int"},{"issue":"1","key":"2022_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12882-018-1107-y","volume":"19","author":"C Gast","year":"2018","unstructured":"Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, Gale DP, Connor TM, Bunyan DJ, Hoda\u0148ov\u00e1 K, et al. Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol. 2018;19(1):301.","journal-title":"BMC Nephrol"},{"issue":"1","key":"2022_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","volume":"5","author":"O Devuyst","year":"2019","unstructured":"Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, Bleyer AJ. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019;5(1):60.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2022_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/0971-4065.167277","volume":"26","author":"D Saxena","year":"2016","unstructured":"Saxena D, Srivastava P, Phadke SR. A novel heterozygous missense mutation in uromodulin gene in an Indian family with familial juvenile hyperuricemic nephropathy. Indian J Nephrol. 2016;26(5):364\u20137.","journal-title":"Indian J Nephrol"},{"issue":"5","key":"2022_CR6","first-page":"791","volume":"36","author":"Y Ying","year":"2018","unstructured":"Ying Y, Chen Y, Zhang S, Huang H, Zou R, Li X, Chu Z, Huang X, Peng Y, Gan M, et al. Investigation of serum biomarkers in primary gout patients using iTRAQ-based screening. Clin Exp Rheumatol. 2018;36(5):791\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2022_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s13730-013-0069-y","volume":"2","author":"A Iguchi","year":"2013","unstructured":"Iguchi A, Eino A, Yamazaki H, Ito T, Saeki T, Ito Y, Imai N, Ohsawa Y, In H, Ichida K, et al. A novel mutation in the uromodulin gene in a Japanese family with a mild phenotype of familial juvenile hyperuricemic nephropathy. CEN Case Rep. 2013;2(2):228\u201333.","journal-title":"CEN Case Rep"},{"issue":"4","key":"2022_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3343\/alm.2013.33.4.293","volume":"33","author":"MN Lee","year":"2013","unstructured":"Lee MN, Jun JE, Kwon GY, Huh WS, Ki CS. A novel UMOD mutation (c.187T>C) in a Korean family with juvenile hyperuricemic nephropathy. Ann Lab Med. 2013;33(4):293\u20136.","journal-title":"Ann Lab Med"},{"issue":"8","key":"2022_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/RHU.0000000000000188","volume":"20","author":"H Spain","year":"2014","unstructured":"Spain H, Plumb T, Mikuls TR. Gout as a manifestation of familial juvenile Hyperuricemic nephropathy. J Clin Rheumatol. 2014;20(8):442\u20134.","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"2022_CR10","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1172\/JCI93817","volume":"127","author":"BG Johnson","year":"2017","unstructured":"Johnson BG, Dang LT, Marsh G, Roach AM, Levine ZG, Monti A, Reyon D, Feigenbaum L, Duffield JS. Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis. J Clin Invest. 2017;127(11):3954\u201369.","journal-title":"J Clin Invest"},{"issue":"5","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","volume":"304","author":"ES Ryu","year":"2013","unstructured":"Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS, Jo I, Johnson RJ, Kang DH. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Ren Physiol. 2013;304(5):F471\u201380.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"9","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrneph.2017.101","volume":"13","author":"O Devuyst","year":"2017","unstructured":"Devuyst O, Olinger E, Rampoldi L. Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol. 2017;13(9):525\u201344.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2022_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.gene.2013.08.041","volume":"531","author":"M Liu","year":"2013","unstructured":"Liu M, Chen Y, Liang Y, Liu Y, Wang S, Hou P, Zhang H, Zhao M. Novel UMOD mutations in familial juvenile hyperuricemic nephropathy lead to abnormal uromodulin intracellular trafficking. Gene. 2013;531(2):363\u20139.","journal-title":"Gene."},{"key":"2022_CR14","doi-asserted-by":"publisher","unstructured":"Malakoutian T, Amouzegar A, Vali F, Asgari M, Behnam B. First report of familial juvenile Hyperuricemic nephropathy (FJHN) in Iran caused by a novel De novo mutation (E197X) in UMOD. J Mol Genet Med. 2016. https:\/\/doi.org\/10.4172\/1747-0862.1000218.","DOI":"10.4172\/1747-0862.1000218"},{"issue":"11","key":"2022_CR15","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1097\/01.ASN.0000092147.83480.B5","volume":"14","author":"K Dahan","year":"2003","unstructured":"Dahan K. A cluster of mutations in the UMOD gene causes familial juvenile Hyperuricemic nephropathy with abnormal expression of Uromodulin. J Am Soc Nephrol. 2003;14(11):2883\u201393.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2022_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1046\/j.1523-1755.2003.00269.x","volume":"64","author":"MT Wolf","year":"2003","unstructured":"Wolf MT, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, et al. Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int. 2003;64(5):1580\u20137.","journal-title":"Kidney Int"},{"issue":"3","key":"2022_CR17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.febslet.2004.10.092","volume":"578","author":"H Yang","year":"2004","unstructured":"Yang H, Wu C, Zhao S, Guo J. Identification and characterization of D8C, a novel domain present in liver-specific LZP, uromodulin and glycoprotein 2, mutated in familial juvenile hyperuricaemic nephropathy. FEBS Lett. 2004;578(3):236\u20138.","journal-title":"FEBS Lett"},{"issue":"5","key":"2022_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"7","key":"2022_CR19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00467-009-1436-y","volume":"25","author":"P Sch\u00e4ffer","year":"2010","unstructured":"Sch\u00e4ffer P, Gombos \u00c9, Meichelbeck K, Kiss A, Hart PS, Bleyer AJ. Childhood course of renal insufficiency in a family with a uromodulin gene mutation. Pediatr Nephrol. 2010;25(7):1355\u201360.","journal-title":"Pediatr Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02022-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:39:10Z","timestamp":1629934750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02022-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"26 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study and procedures were approved by the Research Ethics Committee of the Second Xiangya Hospital, Central South University. Written informed consent was obtained from all contributing family members or their guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written informed consent from the patient\u2019s father to publish this potentially identifiable information from all of the family members included in this case report and accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"368"}}